Nestlé’s Nestea is leaving Germany, so shoppers will no longer see the iced tea brand in grocery stores there. The brand’s exit was revealed this week, and the products will only be around until the end of this month.
Nestea has to be removed from the shelves of retail outlets as the contract of Nestlé Germany with its distribution partner in the country has already expired. As a result, all of Nestea’s Iced Tea products must be sold off by the end of March since the license for the sale has come to an end.
The spokesman of Nestlé Germany refused to say why it has not renewed its agreement with the local distributor. The Nestea products being distributed in the region are produced and directly sold by Nestlé Waters drink company in Switzerland.
Based on the reports, the Nestlé Waters’ division is the one operating the U.S. production and distribution of the brand as it does in the EU countries that are not managed by the unnamed partner distributor in Germany.
At any rate, it was added that Nestea was also traded under a straight license agreement with distributors in various countries such as Romania, Bulgaria, Poland, the Baltics, the Czech Republic, Hungary, and Slovakia.
Nestlé said that as the joint venture with the German distributor has ended, it is high time for them to develop the Nestea brand independently. The company also mentioned that the ready-to-drink (RTD) tea market has advanced, so it is really the right time to expand its Nestea products.
Nestea Iced Tea is a Swiss brand owned by Nestlé but manufactured by The Coca-Cola Company. It is being distributed in the United States by Nestlé's beverage division, and for the rest of the world, Beverage Partners Worldwide stands as its distributor. BPW is a joint venture between Nestlé and Coke soda maker.
Photo by: Slashio Photography/Unsplash


German Exports to the U.S. Decline Sharply as Tariffs Reshape Trade in 2025
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Why U.S. Coffee Prices Are Staying High Despite Trump’s Tariff Rollbacks
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Gold Price Breaks $4,500 as Safe-Haven Demand and Rate Cut Bets Fuel Rally
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
Global Demand for Yuan Loans and Bonds Surges as China Pushes Currency Internationalization
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
U.S. Dollar Slips as Yen Finds Support on Intervention Signals and Geopolitical Risks Rise
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Platinum Price Surges Past $2,000 as Demand and Supply Dynamics Tighten 



